0.8501
price up icon1.89%   0.0158
after-market After Hours: .86 0.0099 +1.16%
loading
Predictive Oncology Inc stock is traded at $0.8501, with a volume of 41,970. It is up +1.89% in the last 24 hours and down -14.22% over the past month. Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
See More
Previous Close:
$0.8343
Open:
$0.8492
24h Volume:
41,970
Relative Volume:
0.02
Market Cap:
$8.93M
Revenue:
$1.52M
Net Income/Loss:
$-13.97M
P/E Ratio:
-0.2787
EPS:
-3.05
Net Cash Flow:
$-13.29M
1W Performance:
-1.15%
1M Performance:
-14.22%
6M Performance:
-29.16%
1Y Performance:
-15.83%
1-Day Range:
Value
$0.83
$0.863
1-Week Range:
Value
$0.81
$0.889
52-Week Range:
Value
$0.55
$3.06

Predictive Oncology Inc Stock (POAI) Company Profile

Name
Name
Predictive Oncology Inc
Name
Phone
412-432-1500
Name
Address
91 43RD STREET, PITTSBURGH, MN
Name
Employee
24
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
POAI's Discussions on Twitter

Compare POAI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
POAI
Predictive Oncology Inc
0.8501 8.93M 1.52M -13.97M -13.29M -3.05
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
544.47 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
176.16 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
87.78 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
256.96 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
222.26 16.36B 2.90B 467.20M 306.90M 6.37

Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-19-24 Initiated H.C. Wainwright Buy

Predictive Oncology Inc Stock (POAI) Latest News

pulisher
Jun 18, 2025

Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Up 50.6% in May - Defense World

Jun 18, 2025
pulisher
Jun 12, 2025

Labcorp (LH) Gains Exclusive 3D Liver Models from Predictive Onc - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology develops liver toxicity models for Labcor By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Inc. Develops Functional 3D Organoid Models Exclusively for Labcorp - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology develops liver toxicity models for Labcor - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - The Manila Times

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Revolutionary 3D Organoid Models: How Predictive Oncology's Exclusive Labcorp Deal Transforms Drug Testing - Stock Titan

Jun 12, 2025
pulisher
Jun 11, 2025

Predictive Oncology Faces Nasdaq Delisting Notice - TipRanks

Jun 11, 2025
pulisher
Jun 07, 2025

Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Major AI Breakthrough in Cancer Research: Leading Pharma Companies Unite in Revolutionary Oncology Initiative - Stock Titan

Jun 05, 2025
pulisher
Jun 02, 2025

SEC Form 424B5 filed by Predictive Oncology Inc. - Quantisnow

Jun 02, 2025
pulisher
Jun 01, 2025

'It's not something you choose to do, it's something you have to do': CEO & artist shares story - WTAE

Jun 01, 2025
pulisher
May 30, 2025

Predictive Oncology (NASDAQ:POAI) Stock Crosses Below 200 Day Moving Average – Time to Sell? - Defense World

May 30, 2025
pulisher
May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology says court denies Renovaro motion for expedited trial - TipRanks

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology (POAI) Addresses Legal Dispute with Renovaro - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July | POAI Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Delaware Court Rejects Renovaro's Rush to Trial Against Predictive Oncology, Cites Critical Delays - Stock Titan

May 27, 2025
pulisher
May 23, 2025

Renovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology Merger - MSN

May 23, 2025
pulisher
May 22, 2025

Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish By Stocktwits - Investing.com India

May 22, 2025
pulisher
May 22, 2025

UPDATERenovaro Inc. Announces Expedited Trial for 2025 Lawsui - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology (POAI) Advances AI-Driven Cancer Drug Discov - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Sues Predictive Oncology (POAI) Over Merger Agreement D - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Gets Expedited Trial in Predictive Oncology Merger Dispute - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Renovaro Sues Predictive Oncology (POAI) Over Merger Agreement Dispute | POAI Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology | RENB Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Secures Ruling to Expedite Trial Against Predictive Oncology Over Breach of Merger Agreement - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Court Fast-Tracks Renovaro's Lawsuit to Force Predictive Oncology Merger After 50% Stock Jump Drama - Stock Titan

May 22, 2025
pulisher
May 22, 2025

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition | POAI Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology harnesses AI for drug discovery - Investing.com

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology moves to leverage biobank using AI - TipRanks

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology harnesses AI for drug discovery By Investing.com - Investing.com Nigeria

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology Inc. Advances AI-Driven Drug Discovery with Extensive Biobank of Tumor Samples - Nasdaq

May 22, 2025
pulisher
May 22, 2025

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Major AI Breakthrough: How 150,000 Live Tumor Samples Are Revolutionizing Cancer Drug Discovery - Stock Titan

May 22, 2025
pulisher
May 20, 2025

Predictive Oncology issued shareholder letter - TipRanks

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology (POAI) Showcases Recent Achievements and Future Plans | POAI Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Expands AI-Driven Platform to Include Biomarker Discovery and Drug Repurposing for Precision Oncology - Nasdaq

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: ... - Bluefield Daily Telegraph

May 20, 2025

Predictive Oncology Inc Stock (POAI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$78.50
price up icon 0.32%
$196.82
price down icon 0.08%
medical_instruments_supplies COO
$73.30
price up icon 0.38%
$64.78
price down icon 0.80%
medical_instruments_supplies BAX
$31.01
price down icon 0.39%
medical_instruments_supplies WST
$222.26
price up icon 0.47%
Cap:     |  Volume (24h):